|
2025
|
G/S
|
Anti-infectives; anti-inflammatories; antibacterial pharmaceuticals; antibiotics; antifungal prep... |
|
|
G/S
|
Pharmaceutical preparations. |
|
|
G/S
|
providing an internet website portal offering the sale of products in the field of health and med... |
|
2024
|
G/S
|
Logiciels téléchargeables pour la fourniture d'informations médicales et pharmaceutiques aux pati... |
|
|
G/S
|
Downloadable software for use in providing medical and pharmaceutical information for patients; d... |
|
|
G/S
|
Downloadable software for use in providing medical and
pharmaceutical information for patients; ... |
|
|
G/S
|
Préparations pharmaceutiques pour la prévention et le traitement du système nerveux central, à sa... |
|
|
G/S
|
Services de conseils en affaires dans le domaine de la mise en place, de la pratique et du foncti... |
|
|
G/S
|
Business consulting services in the field involving the implementation, practice and operation of... |
|
|
G/S
|
Business consulting services in the field involving the
implementation, practice and operation o... |
|
|
G/S
|
Business consulting services in the field of set-up,
practice and operation of radioligand imagi... |
|
|
G/S
|
Providing a web site featuring medical information; providing medical information in the field of... |
|
|
Invention
|
S1p modulator immediate release dosage regimen.
The present invention relates to siponimod (BAB3... |
|
|
Invention
|
Nlrp3 inflammasome inhibitors.
The present invention relates to novel pyridazin-3-yl phenol comp... |
|
|
Invention
|
Dosage regimens for anti-pd-l1 antibodies and uses thereof.
Antibody molecules that specifically... |
|
|
Invention
|
3-(5-oxy)-1-oxoisoindolin-2-yl)piperidine-2,6-dione derivatives and uses thereof.
The present di... |
|
|
Invention
|
Pharmaceutical products and stable liquid compositions of il-17 antibodies.
The disclosure is di... |
|
|
Invention
|
Selective reduction of cysteine residues in il-17 antibodies.
The present disclosure relates to ... |
|
|
Invention
|
Compositions and methods of use for therapeutic antibodies.
The present invention relates to ant... |
|
|
Invention
|
Crystalline forms of a tlr7/tlr8 inhibitor.
This application relates to various crystalline form... |
|
|
Invention
|
Human mesothelin chimeric antigen receptors and uses thereof.
Provided are compositions and meth... |
|
|
Invention
|
New uses of omalizumab. 150mg/mL omalizumab formulation for use in a method of treatment of one o... |
|
|
Invention
|
Compounds and compositions for treating conditions associated with nlrp activity.
In one aspect,... |
|
|
Invention
|
Psma-targeting radioligand treatment regimen. Described herein are radiopharmaceuticals for the t... |
|
|
Invention
|
Biaryl derivatives as yap/taz-tead protein-protein interaction inhibitors.
The present invention... |
|
|
Invention
|
Method of treating prostate cancer. The present disclosure relates to a method of treating prosta... |
|
|
Invention
|
Sodium channel blockers.
The present disclosure relates to sulfonamide compounds, the use thereo... |
|
|
Invention
|
Sodium channel blockers. The present disclosure relates to sulfonamide compounds, the use thereof... |
|
|
Invention
|
10-(di(phenyl)methyl)-4-hydroxy-8,9,9a,10-tetrahydro-7h-pyrrolo[1 ',2':4,5]pyrazino[1,2-b]pyridaz... |
|
|
Invention
|
Anti-ige antibody therapy for multiple food allergies.
The present disclosure provides methods a... |
|
|
Invention
|
Bispecific antibodies for use in treatment of patients with xiap deficiency or cdc42 mutations. T... |
|
|
Invention
|
Method and apparatus for using omalizumab.
A method of treating a patient with of one or more of... |
|
|
Invention
|
Fused tricyclic pyridazinone compounds useful to treat orthomyxovirus infections.
The invention ... |
|
|
Invention
|
Combination.
A novel combination comprising a 17 α-hydroxylase/C17,20 lyase inhibitor, for examp... |
|
|
Invention
|
Naphthyridinone derivatives for the treatment of a disease or disorder.
The present disclosure r... |
|
|
Invention
|
Naphthyridinone derivatives for the treatment of a disease or disorder. The present disclosure re... |
|
|
Invention
|
Compositions and methods for treating b-lymphoid malignancies.
Compositions and methods for inhi... |
|
|
Invention
|
Method of manufacturing bispecific antibodies, bispecific antibodies and therapeutic use of such ... |
|
|
Invention
|
Il-18 binding molecules.
IL-18 participates in both innate and acquired immunity. The bioactivit... |
|
|
Invention
|
Compositions and methods for selective protein degradation.
The invention provides compositions ... |
|
|
Invention
|
Use of labeled inhibitors of prostate specific membrane antigen (psma), as agents for the treatme... |
|
|
Invention
|
Cd19 and cd22 chimeric antigen receptors and uses thereof.
The present disclosure provides compo... |
|
|
Invention
|
Methods of using factor b inhibitors.
Described herein are methods of treating paroxysmal noctur... |
|
|
Invention
|
Heteroaromatic nmda receptor modulators and uses thereof.
Provided is 5-(3-chloro-4-fluorophenyl... |
|
|
Invention
|
Compositions and methods for increasing muscle growth.
This disclosure is in the field of anti-A... |
|
|
Invention
|
Fgfr inhibitor for use in the treatment of hypophosphatemic disorders.
The present invention rel... |
|
2023
|
Invention
|
Methods of treating chronic spontaneous urticaria using ligelizumab.
The present disclosure rela... |
|
|
Invention
|
Methods for improving the efficacy and expansion of chimeric antigen receptor-expressing cells.
... |
|
|
Invention
|
Compositions and methods for immunooncology.
The present invention is directed to genome editing... |
|
|
Invention
|
Anti-ige antibody therapy for multiple food allergies. The present disclosure provides methods an... |
|
2022
|
Invention
|
Methods of treatment using lou064.
The present disclosure relates to methods of treating and/or ... |
|
|
Invention
|
Staggered triple lipid-modified nucleic acid compounds.
Disclosed herein are compounds including... |
|
|
Invention
|
Combination therapy for treating lung cancer.
The present invention relates to methods for treat... |
|
|
Invention
|
Methods for determining the biological activity of angptl polypeptides.
Provided herein are meth... |
|
|
Invention
|
Engineered fc variants.
The present invention describes engineered immunoglobulin IgG Fc regions... |
|
|
Invention
|
A computer implemented method for assessing and determining a complexity level of a clinical tria... |
|
|
Invention
|
Novel transcription factors.
The present invention relates to novel transcription factors for mo... |
|
|
Invention
|
Use of factor b inhibitors for the treatment of age-related macular degeneration.
Described here... |
|
|
Invention
|
Crystalline forms of biaryl yap/taz-tead protein-protein interaction inhibitors.
The present inv... |
|
|
Invention
|
Bifunctional degraders comprising a tead binder.
The present disclosure relates to a conjugate c... |
|
2019
|
Invention
|
Novel dosing regimens for mdm2 inhibitors.
The present invention relates to the HDM2-p53 interac... |
